The Power of PrEP – Towards 2030 Elimination Goals - Nyaradzo Mavis Mgodi, MBChB, MMed

INTEREST 2024

Treatment as Prevention – How Can We Improve the Third 95? - François Venter, MD, FCP, PhD

INTEREST 2024

HIV Response Within the Key Populations in Benin: Lessons Learned, Challenges, and Perspectives - Carin Ahouada, MD, MBA, MSc

INTEREST 2024

Paediatric HIV and Transition from Adolescent to Adult Sites in Benin - Léhila Bagnan Tossa, MD, MCA

INTEREST 2024

Overview of the HIV Response and Management in Benin - Valentine Kiki-Medegan, MD, MSc, DEA, DUES

INTEREST 2024

Overview of the HIV Response and Management in Benin - Djimon Marcel Zannou, MD, PT

INTEREST 2024

Comparaison du Profil de Résistance dans l'ARN Viral et l'ADN Proviral chez les Adolescents sous Traitement Antirétroviral avec Virémie Détectable au Cameroun - Armando Blondel Djiyou Djeuda, Cameroon

INTEREST 2024

Sexualité Chez Les Adolescents Infectés AU VIH Suivis AU Sein Des Cohortes de Deux Hôpitaux Universitaires AU Sud du Bénin - Lutécia Zohoun, Bénin

INTEREST 2024

Molecular Epidemiology of Human Papillomavirus Circulating in African Countries: Adequacies with HIV-Infection and Oncogenesis, Systematic Review and Meta-Analysis - Larissa Gaelle Moko Fotso, Cameroon

INTEREST 2024

Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1 Infections - James Kangethe, Kenya

INTEREST 2024